NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579 | -100.0% | 35,853 | +38.4% | 0.01% | -71.4% |
| Q3 2022 | $1,968,000 | +578.6% | 25,908 | +519.1% | 0.02% | +600.0% |
| Q2 2022 | $290,000 | -86.5% | 4,185 | -85.4% | 0.00% | -75.0% |
| Q4 2021 | $2,152,000 | -62.0% | 28,671 | -41.2% | 0.01% | -65.7% |
| Q3 2021 | $5,660,000 | +94.5% | 48,726 | -0.7% | 0.04% | -59.8% |
| Q2 2020 | $2,910,000 | +556.9% | 49,088 | +646.1% | 0.09% | +200.0% |
| Q1 2020 | $443,000 | -69.5% | 6,579 | -66.2% | 0.03% | -58.0% |
| Q3 2019 | $1,453,000 | – | 19,436 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |